Literature DB >> 27219118

The STBUR questionnaire for identifying children at risk for sleep-disordered breathing and postoperative opioid-related adverse events.

Alan R Tait1, Rebecca Bickham1,2, Louise M O'Brien3,4,5, Megan Quinlan1,2, Terri Voepel-Lewis1.   

Abstract

BACKGROUND: Children with symptoms of sleep-disordered breathing (SDB) appear to be at risk for perioperative respiratory events (PRAE). Furthermore, these children may be more sensitive to the respiratory-depressant effects of opioids compared with children without SDB. AIMS: The aim of this prospective observational study was to confirm that otherwise healthy children with symptoms of SDB are at greater risk for PRAE compared with children with no symptoms and to determine if these children are also at increased risk for postoperative opioid-related adverse events (ORAE).
METHODS: Six hundred and seventy-eight parents of children scheduled for surgery completed the Snoring, Trouble Breathing, and Un-Refreshed (STBUR) questionnaire preoperatively. Data regarding the incidence of PRAE were collected prospectively. Postoperative pulse oximetry desaturation alarm events were downloaded from the institutional secondary alarm notification system.
RESULTS: Children with symptoms of SDB per STBUR (≥3 symptoms) had a two-fold increased likelihood of PRAE compared with children without SDB (52.8% vs 27.9% respectively, LR(+) = 2.00, 95% CI = 1.60-2.49, P = 0.0001). A subset analysis of children undergoing airway procedures requiring hospital admittance (n = 179) showed that those with SDB were given the same postoperative opioid doses as children without SDB. However, children with SDB symptoms generated a greater number of postoperative oxygen desaturation alarms (14.14 ± 29.3 vs 7.12 ± 13.2, mean difference = 7.02, 95% CI = 0.39-13.64, P = 0.038) and more frequently required escalation of care (15.3% vs 7.1%, LR(+) = 1.67, 95% CI = 1.22-2.16, P = 0.001) compared with children with no SDB symptoms.
CONCLUSIONS: Children presenting for surgery with SDB symptoms are at increased risk for PRAE. Children undergoing airway-related procedures also appear to be at increased risk for ORAE. Furthermore, regardless of the preoperative assessment of risk using the STBUR questionnaire, children received the same doses of opioids postoperatively. Given the increased incidence of postoperative oxygen desaturations among children with SDB symptoms, it would seem prudent to consider titration of opioid doses according to identified risk.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  adverse events; child; opioids; perioperative; sleep-disordered breathing

Mesh:

Substances:

Year:  2016        PMID: 27219118     DOI: 10.1111/pan.12934

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  5 in total

Review 1.  Paediatric adenotonsillectomy, part 1: surgical perspectives relevant to the anaesthetist.

Authors:  K T Murto; J Zalan; J-P Vaccani
Journal:  BJA Educ       Date:  2020-04-25

Review 2.  [German S1 guideline: obstructive sleep apnea in the context of tonsil surgery with or without adenoidectomy in children-perioperative management].

Authors:  G Badelt; C Goeters; K Becke-Jakob; T Deitmer; C Eich; C Höhne; B A Stuck; A Wiater
Journal:  HNO       Date:  2020-12-22       Impact factor: 1.284

3.  Clinical Prediction Rules, Adenotonsillectomy and Children With Obstructive Sleep Apnea: What's Next?

Authors:  Kimmo Murto
Journal:  J Clin Sleep Med       Date:  2017-12-15       Impact factor: 4.062

4.  Association of sleep disordered breathing symptoms with early postoperative analgesic requirement in pediatric ambulatory surgical patients.

Authors:  Kamie Yang; Anne Baetzel; Wilson T Chimbira; Yuliya Yermolina; Paul I Reynolds; Olubukola O Nafiu
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2017-03-19       Impact factor: 1.675

5.  Use of the Snoring, Trouble Breathing, Un-Refreshed questionnaire to predict perioperative respiratory adverse events in children.

Authors:  Javier Huerta; Hannah Taleu; Rene Norton; Heike Gries; Philip Yun; Derek Lam
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.